中国组织工程研究 ›› 2024, Vol. 28 ›› Issue (31): 4958-4963.doi: 10.12307/2024.199

• 骨髓干细胞 bone marrow stem cells • 上一篇    下一篇

血管内皮生长因子联合碱性成纤维细胞生长因子改善骨髓间充质干细胞复制性衰老

施伟丽1,2,刘珊珊1,2,常红波1,2,高海霞2,王新洲2,秦  楠2,吴  鸿1,2   

  1. 1河南中医药大学第二临床医学院,河南省郑州市   450002;2河南省中医院中心实验室,河南省郑州市   450002
  • 收稿日期:2023-06-10 接受日期:2023-09-11 出版日期:2024-11-08 发布日期:2024-01-22
  • 通讯作者: 吴鸿,博士,主任医师,博士生导师, 河南中医药大学第二临床医学院,河南省郑州市 450002;河南省中医院中心实验室,河南省郑州市 450002
  • 作者简介:施伟丽,女,1987年生,河南省新密市人,2017年中国中医科学院毕业,博士,讲师,主要从事中医药防治心血管病研究。
  • 基金资助:
    国家自然科学基金青年项目(81803771),项目负责人:施伟丽;河南省中医药科学研究专项(2021JDZX2018),项目负责人:施伟丽

Vascular endothelial growth factor combined with basic fibroblast growth factor improves replicative senescence of bone marrow mesenchymal stem cells

Shi Weili1, 2, Liu Shanshan1, 2, Chang Hongbo1, 2, Gao Haixia2, Wang Xinzhou2, Qin Nan2, Wu Hong1, 2   

  1. 1Second Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou 450002, Henan Province, China; 2Central Laboratory of Henan Province Hospital of TCM, Zhengzhou 450002, Henan Province, China
  • Received:2023-06-10 Accepted:2023-09-11 Online:2024-11-08 Published:2024-01-22
  • Contact: Wu Hong, MD, Chief physician, Doctoral supervisor, Second Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou 450002, Henan Province, China; Central Laboratory of Henan Province Hospital of TCM, Zhengzhou 450002, Henan Province, China
  • About author:Shi Weili, MD, Lecturer, Second Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou 450002, Henan Province, China; Central Laboratory of Henan Province Hospital of TCM, Zhengzhou 450002, Henan Province, China
  • Supported by:
    National Natural Science Foundation (Youth Project), No. 81803771 (to SWL); Henan Province Traditional Chinese Medicine Science Research Project, No. 2021JDZX2018 (to SWL)

摘要:


文题释义:

复制性衰老:是细胞由于不断地分裂,造成端粒缩短,从而达到 Hayflick 极限,导致细胞退出细胞周期的现象。
间充质干细胞:是中胚层来源的具有高度自我更新能力和多向分化潜能的多能干细胞,并能在特定条件下分化为成骨、软骨、脂肪等

细胞。


背景:间充质干细胞在体外扩增过程中易衰老,极大地阻碍了其体内外应用,如何改善间充质干细胞的复制性衰老,是组织工程学亟待解决的问题。

目的:探讨血管内皮生长因子联合碱性成纤维细胞生长因子能否改善复制性传代导致的骨髓间充质干细胞衰老。
方法:全骨髓贴壁法提取大鼠骨髓间充质干细胞,选取第2代细胞为正常对照组,第7代及以后代数细胞为衰老模型组,给予血管内皮生长因子(50 μg/L)、碱性成纤维细胞生长因子(10 μg/L)及二者联合干预。CCK-8法检测细胞增殖情况,β-半乳糖苷酶活性染色观察细胞衰老情况,鬼笔环肽染色和吉姆萨染色分别观察细胞骨架大小及集落形成能力,qRT-PCR检测衰老相关基因P16、P21和P53表达水平。

结果与结论:①血管内皮生长因子联合碱性成纤维细胞生长因子可促进衰老骨髓间充质干细胞的增殖,第9天开始进入平台期,且第9天联合干预组吸光度值较模型组明显升高(P < 0.05);②联合干预组细胞表型标记物未见改变,细胞形态由宽大变细长;③与模型组比较,联合干预组β-半乳糖苷酶阳性率显著降低(P < 0.01);细胞核个数增加(P < 0.001);细胞骨架总面积增加(P < 0.01);集落形成能力增强(P < 0.05);P16表达水平降低(P < 0.01)。以上结果提示:血管内皮生长因子联合碱性成纤维细胞生长因子可改善复制性传代导致的骨髓间充质干细胞衰老,且不改变细胞表型。

https://orcid.org/0000-0002-3289-9255 (施伟丽) 

中国组织工程研究杂志出版内容重点:干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程

关键词: 血管内皮生长因子, 碱性成纤维细胞生长因子, 骨髓间充质干细胞, 复制性衰老

Abstract: BACKGROUND: Mesenchymal stem cells are susceptible to senescence during in vitro expansion, which greatly hinders their application in vivo and in vitro. How to improve the replicative senescence of mesenchymal stem cells is an urgent problem to be solved in tissue engineering.
OBJECTIVE: To determine whether vascular endothelial growth factor combined with basic fibroblast growth factor can improve the aging of bone marrow mesenchymal stem cells caused by replicative passage.
METHODS: Rat bone marrow mesenchymal stem cells were extracted by whole bone marrow adhesion method. Passage 2 cells were selected as normal control group. Passage 7 and later algebraic cells were selected as aging model group. Vascular endothelial growth factor (50 μg/L), basic fibroblast growth factor (10 μg/L), and their combination were administered. Cell proliferation was detected by CCK-8 assay. Cell senescence was observed by β-galactosidase activity staining. Cytoskeleton size and colony formation ability were observed by phalloidine staining and Giemsa staining, respectively, and the levels of senescence-related genes P16, P21, and P53 were detected by qRT-PCR. Gene expression levels of P16, P21, and P53 were tested by qRT-PCR.
RESULTS AND CONCLUSION: (1) Vascular endothelial growth factor combined with basic fibroblast growth factor could promote the proliferation of aged bone marrow mesenchymal stem cells, which began to enter the plateau stage on day 9, and the absorbance value of the combined intervention group was significantly higher than that of the model group on day 9 (P < 0.05). (2) The phenotypic markers of the cells in the combined intervention group did not change, and the cell morphology changed from broad to slender. (3) Compared with the model group, the positive rate of β-galactosidase was significantly decreased (P < 0.01); the number of nuclei increased (P < 0.001); the total area of cytoskeleton increased (P < 0.01); colony formation ability was enhanced (P < 0.05); expression level of P16 was decreased (P < 0.01) in the combined intervention group. These results indicate that vascular endothelial growth factor combined with basic fibroblast growth factor can improve the senescence of bone marrow mesenchymal stem cells caused by replicative passage without changing the cell phenotype. 

Key words: vascular endothelial growth factor, basic fibroblast growth factor, bone marrow mesenchymal stem cell, replicative senescence

中图分类号: